More importantly, differentially methylated CpGs between ER+ and ER- breast cancer are enriched in the DNA regions surrounding ERα binding peaks (determined by ChIP-seq) in a distance dependent manner—the closer to the center of binding peaks, the more differentially methylated the CpGs tend to be [31]. The gene discussed is ESR1; the disease is breast carcinoma.